ABBV vs ZTS
By Alex · Tickerpine
AbbVie Inc. vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | ZTS |
|---|---|---|
| Price | $253.35 | $76.09 |
| Market cap | $447.62B | $31.90B |
| P/E ratio | 123.6 | 12.5 |
| ROE | — | 67.75% |
| Profit margin | 5.79% | 28.04% |
| Revenue growth | 12.40% | 2.90% |
| Dividend yield | 2.73% | 2.79% |
| Beta | 0.31 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs ZTS in plain English
- ABBV is the bigger company — about 14.0× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 12.5 vs 123.6).
- ABBV is growing revenue faster (12% vs 3%).
- ZTS has the higher dividend yield (2.79% vs 2.73%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.